Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.
Latest News
May 18, 2010Pearl Therapeutics’ Data for its...
May 17, 2010Pearl Therapeutics Receives TiE50...
May 5, 2010Pearl Therapeutics’ Bronchodilator...
More Press Releases